SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-040624
Filing Date
2022-11-09
Accepted
2022-11-09 11:15:21
Documents
15
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10043925_8k.htm   iXBRL 8-K 27899
2 EXHIBIT 99.1 brhc10043925_ex99-1.htm EX-99.1 368474
6 image0.jpg GRAPHIC 8345
7 image1.jpg GRAPHIC 803
  Complete submission text file 0001140361-22-040624.txt   568732

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20221109.xsd EX-101.SCH 3875
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20221109_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20221109_pre.xml EX-101.PRE 16051
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10043925_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 221371223
SIC: 2834 Pharmaceutical Preparations